Lombard Odier Asset Management (USA)’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
VCM
VPM
Lombard Odier Asset Management (USA)'s BMY Position: Q1 2022 in Review
Lombard Odier Asset Management (USA) sold out of Bristol-Myers Squibb (BMY) in Q1 2022, closing a stake of 60,000 shares — an estimated $3.74M sold.
Lombard Odier Asset Management (USA) first reported a position in BMY in Q2 2013 and held it in 7 quarters. The position peaked at $22.1M in Q1 2014. 2,516 funds tracked by Wall St. Rank hold BMY as of Q1 2022.
- Lombard Odier Asset Management (USA) reported no remaining Bristol-Myers Squibb position as of Q1 2022 after selling out during the quarter.
- Lombard Odier Asset Management (USA) sold 60,000 Bristol-Myers Squibb shares in Q1 2022, an estimated $3.74M.
- Lombard Odier Asset Management (USA) first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 7 quarters.
- Lombard Odier Asset Management (USA)'s Bristol-Myers Squibb position peaked at $22.1M in Q1 2014.
- 2,516 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2022.
Based on Lombard Odier Asset Management (USA)'s 13F filing for Q1 2022, filed 16 May 2022.